APO Research
Talk to an analyst

APO RESEARCH · REPORT

Female Sexual Dysfunction Treatment

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Female Sexual Dysfunction Treatment Market Analysis and Forecast 2026-2032

22 December 2025194 pages

Choose your research edition.

Industry ResearchFemale Sexual Dysfunction Treatment Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Female Sexual Dysfunction Treatment Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Female Sexual Dysfunction Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Female Sexual Dysfunction Treatment Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Female Sexual Dysfunction Treatment Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Female Sexual Dysfunction Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Female Sexual Dysfunction Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Female Sexual Dysfunction Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Female Sexual Dysfunction Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Female Sexual Dysfunction Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Female Sexual Dysfunction Treatment include Novo Nordisk AS, Sprout Pharmaceuticals Inc., Emotional Brain BV, Duchesnay Inc. and AMAG Pharmaceuticals Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Female Sexual Dysfunction Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Female Sexual Dysfunction Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for Female Sexual Dysfunction Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Female Sexual Dysfunction Treatment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Female Sexual Dysfunction Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Female Sexual Dysfunction Treatment revenue, projected growth trends, production technology, application and end-user industry.

Female Sexual Dysfunction Treatment Segment by Company

Novo Nordisk AS

Sprout Pharmaceuticals Inc.

Emotional Brain BV

Duchesnay Inc.

AMAG Pharmaceuticals Inc.

Female Sexual Dysfunction Treatment Segment by Type

Non-hormonal Therapy

Hormonal Therapy

Female Sexual Dysfunction Treatment Segment by Application

Pelvic Floor Dysfunction

Post-orgasmic Diseases

Orgasm Disorders

Sexual Arousal Disorders

Sexual Pain Disorders

Sexual Desire Disorders

Other

Female Sexual Dysfunction Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Female Sexual Dysfunction Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Female Sexual Dysfunction Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Female Sexual Dysfunction Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Female Sexual Dysfunction Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Female Sexual Dysfunction Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Female Sexual Dysfunction Treatment revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Female Sexual Dysfunction Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Non-hormonal Therapy Major Player Table 3. Hormonal Therapy Major Player Table 4. Global Female Sexual Dysfunction Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Pelvic Floor Dysfunction Major Player Table 6. Post-orgasmic Diseases Major Player Table 7. Orgasm Disorders Major Player Table 8. Sexual Arousal Disorders Major Player Table 9. Sexual Pain Disorders Major Player Table 10. Sexual Desire Disorders Major Player Table 11. Other Major Player Table 12. Female Sexual Dysfunction Treatment Industry Trends Table 13. Female Sexual Dysfunction Treatment Industry Drivers Table 14. Female Sexual Dysfunction Treatment Industry Opportunities and Challenges Table 15. Female Sexual Dysfunction Treatment Industry Restraints Table 16. Global Female Sexual Dysfunction Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Female Sexual Dysfunction Treatment Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Female Sexual Dysfunction Treatment Market Share by Region (2021-2026) Table 19. Global Female Sexual Dysfunction Treatment Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Female Sexual Dysfunction Treatment Market Share by Region (2027-2032) Table 21. Global Female Sexual Dysfunction Treatment Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Female Sexual Dysfunction Treatment Revenue Market Share by Players (2021-2026) Table 23. Global Female Sexual Dysfunction Treatment Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Female Sexual Dysfunction Treatment Key Players Headquarters & Area Served Table 25. Global Female Sexual Dysfunction Treatment Players, Product Type & Application Table 26. Global Female Sexual Dysfunction Treatment Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Female Sexual Dysfunction Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Female Sexual Dysfunction Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Female Sexual Dysfunction Treatment Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Female Sexual Dysfunction Treatment Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Female Sexual Dysfunction Treatment Revenue Market Share by Type (2021-2026) Table 33. Global Female Sexual Dysfunction Treatment Revenue Market Share by Type (2027-2032) Table 34. Global Female Sexual Dysfunction Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Female Sexual Dysfunction Treatment Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Female Sexual Dysfunction Treatment Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Female Sexual Dysfunction Treatment Revenue Market Share by Application (2021-2026) Table 38. Global Female Sexual Dysfunction Treatment Revenue Market Share by Application (2027-2032) Table 39. Novo Nordisk AS Company Information Table 40. Novo Nordisk AS Business Overview Table 41. Novo Nordisk AS Female Sexual Dysfunction Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Novo Nordisk AS Female Sexual Dysfunction Treatment Product Portfolio Table 43. Novo Nordisk AS Recent Development Table 44. Sprout Pharmaceuticals Inc. Company Information Table 45. Sprout Pharmaceuticals Inc. Business Overview Table 46. Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Product Portfolio Table 48. Sprout Pharmaceuticals Inc. Recent Development Table 49. Emotional Brain BV Company Information Table 50. Emotional Brain BV Business Overview Table 51. Emotional Brain BV Female Sexual Dysfunction Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Emotional Brain BV Female Sexual Dysfunction Treatment Product Portfolio Table 53. Emotional Brain BV Recent Development Table 54. Duchesnay Inc. Company Information Table 55. Duchesnay Inc. Business Overview Table 56. Duchesnay Inc. Female Sexual Dysfunction Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Duchesnay Inc. Female Sexual Dysfunction Treatment Product Portfolio Table 58. Duchesnay Inc. Recent Development Table 59. AMAG Pharmaceuticals Inc. Company Information Table 60. AMAG Pharmaceuticals Inc. Business Overview Table 61. AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Product Portfolio Table 63. AMAG Pharmaceuticals Inc. Recent Development Table 64. North America Female Sexual Dysfunction Treatment Revenue by Type (2021-2026) & (US$ Million) Table 65. North America Female Sexual Dysfunction Treatment Revenue by Type (2027-2032) & (US$ Million) Table 66. North America Female Sexual Dysfunction Treatment Revenue by Application (2021-2026) & (US$ Million) Table 67. North America Female Sexual Dysfunction Treatment Revenue by Application (2027-2032) & (US$ Million) Table 68. North America Female Sexual Dysfunction Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 69. North America Female Sexual Dysfunction Treatment Revenue by Country (2021-2026) & (US$ Million) Table 70. North America Female Sexual Dysfunction Treatment Revenue by Country (US$ Million) & (2027-2032) Table 71. Europe Female Sexual Dysfunction Treatment Revenue by Type (2021-2026) & (US$ Million) Table 72. Europe Female Sexual Dysfunction Treatment Revenue by Type (2027-2032) & (US$ Million) Table 73. Europe Female Sexual Dysfunction Treatment Revenue by Application (2021-2026) & (US$ Million) Table 74. Europe Female Sexual Dysfunction Treatment Revenue by Application (2027-2032) & (US$ Million) Table 75. Europe Female Sexual Dysfunction Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 76. Europe Female Sexual Dysfunction Treatment Revenue by Country (2021-2026) & (US$ Million) Table 77. Europe Female Sexual Dysfunction Treatment Revenue by Country (US$ Million) & (2027-2032) Table 78. China Female Sexual Dysfunction Treatment Revenue by Type (2021-2026) & (US$ Million) Table 79. China Female Sexual Dysfunction Treatment Revenue by Type (2027-2032) & (US$ Million) Table 80. China Female Sexual Dysfunction Treatment Revenue by Application (2021-2026) & (US$ Million) Table 81. China Female Sexual Dysfunction Treatment Revenue by Application (2027-2032) & (US$ Million) Table 82. Asia Female Sexual Dysfunction Treatment Revenue by Type (2021-2026) & (US$ Million) Table 83. Asia Female Sexual Dysfunction Treatment Revenue by Type (2027-2032) & (US$ Million) Table 84. Asia Female Sexual Dysfunction Treatment Revenue by Application (2021-2026) & (US$ Million) Table 85. Asia Female Sexual Dysfunction Treatment Revenue by Application (2027-2032) & (US$ Million) Table 86. Asia Female Sexual Dysfunction Treatment Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 87. Asia Female Sexual Dysfunction Treatment Revenue by Region (US$ Million) & (2021-2026) Table 88. Asia Female Sexual Dysfunction Treatment Revenue by Region (US$ Million) & (2027-2032) Table 89. SAMEA Female Sexual Dysfunction Treatment Revenue by Type (2021-2026) & (US$ Million) Table 90. SAMEA Female Sexual Dysfunction Treatment Revenue by Type (2027-2032) & (US$ Million) Table 91. SAMEA Female Sexual Dysfunction Treatment Revenue by Application (2021-2026) & (US$ Million) Table 92. SAMEA Female Sexual Dysfunction Treatment Revenue by Application (2027-2032) & (US$ Million) Table 93. SAMEA Female Sexual Dysfunction Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. SAMEA Female Sexual Dysfunction Treatment Revenue by Country (2021-2026) & (US$ Million) Table 95. SAMEA Female Sexual Dysfunction Treatment Revenue by Country (US$ Million) & (2027-2032) Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Female Sexual Dysfunction Treatment Image Figure 2. Global Female Sexual Dysfunction Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Female Sexual Dysfunction Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Non-hormonal Therapy Image Figure 5. Hormonal Therapy Image Figure 6. Global Female Sexual Dysfunction Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Female Sexual Dysfunction Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 8. Pelvic Floor Dysfunction Image Figure 9. Post-orgasmic Diseases Image Figure 10. Orgasm Disorders Image Figure 11. Sexual Arousal Disorders Image Figure 12. Sexual Pain Disorders Image Figure 13. Sexual Desire Disorders Image Figure 14. Other Image Figure 15. Global Female Sexual Dysfunction Treatment Market Size (US$ Million) & (2021-2032) Figure 16. Global Female Sexual Dysfunction Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Female Sexual Dysfunction Treatment Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Female Sexual Dysfunction Treatment Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Female Sexual Dysfunction Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Female Sexual Dysfunction Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Female Sexual Dysfunction Treatment Revenue Market Share by Type (2021-2032) Figure 23. Global Female Sexual Dysfunction Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Female Sexual Dysfunction Treatment Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Female Sexual Dysfunction Treatment Revenue Market Share by Application (2021-2032) Figure 26. North America Female Sexual Dysfunction Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Female Sexual Dysfunction Treatment Revenue Share by Type (2021-2032) Figure 28. North America Female Sexual Dysfunction Treatment Revenue Share by Application (2021-2032) Figure 29. North America Female Sexual Dysfunction Treatment Revenue Share by Country (2021-2032) Figure 30. United States Female Sexual Dysfunction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Female Sexual Dysfunction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Female Sexual Dysfunction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Female Sexual Dysfunction Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Female Sexual Dysfunction Treatment Revenue Share by Type (2021-2032) Figure 35. Europe Female Sexual Dysfunction Treatment Revenue Share by Application (2021-2032) Figure 36. Europe Female Sexual Dysfunction Treatment Revenue Share by Country (2021-2032) Figure 37. Germany Female Sexual Dysfunction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Female Sexual Dysfunction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Female Sexual Dysfunction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Female Sexual Dysfunction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Female Sexual Dysfunction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Female Sexual Dysfunction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Female Sexual Dysfunction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Female Sexual Dysfunction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Female Sexual Dysfunction Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Female Sexual Dysfunction Treatment Revenue Share by Type (2021-2032) Figure 47. China Female Sexual Dysfunction Treatment Revenue Share by Application (2021-2032) Figure 48. Asia Female Sexual Dysfunction Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Female Sexual Dysfunction Treatment Revenue Share by Type (2021-2032) Figure 50. Asia Female Sexual Dysfunction Treatment Revenue Share by Application (2021-2032) Figure 51. Asia Female Sexual Dysfunction Treatment Revenue Share by Region (2021-2032) Figure 52. Japan Female Sexual Dysfunction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Female Sexual Dysfunction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Female Sexual Dysfunction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Female Sexual Dysfunction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Female Sexual Dysfunction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Female Sexual Dysfunction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Female Sexual Dysfunction Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Female Sexual Dysfunction Treatment Revenue Share by Type (2021-2032) Figure 60. SAMEA Female Sexual Dysfunction Treatment Revenue Share by Application (2021-2032) Figure 61. SAMEA Female Sexual Dysfunction Treatment Revenue Share by Country (2021-2032) Figure 62. Brazil Female Sexual Dysfunction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Female Sexual Dysfunction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Female Sexual Dysfunction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Female Sexual Dysfunction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Female Sexual Dysfunction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Female Sexual Dysfunction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Female Sexual Dysfunction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Female Sexual Dysfunction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Female Sexual Dysfunction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Female Sexual Dysfunction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Female Sexual Dysfunction Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Non-hormonal Therapy
  • Hormonal Therapy
Applications
  • Pelvic Floor Dysfunction
  • Post-orgasmic Diseases
  • Orgasm Disorders
  • Sexual Arousal Disorders
  • Sexual Pain Disorders
  • Sexual Desire Disorders
  • Other
Companies covered
  • Novo Nordisk AS
  • Sprout Pharmaceuticals Inc.
  • Emotional Brain BV
  • Duchesnay Inc.
  • AMAG Pharmaceuticals Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Female Sexual Dysfunction Treatment Market by Type
  3. 1.2.1 Global Female Sexual Dysfunction Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Non-hormonal Therapy
  5. 1.2.3 Hormonal Therapy
  6. 1.3 Female Sexual Dysfunction Treatment Market by Application
  7. 1.3.1 Global Female Sexual Dysfunction Treatment Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Pelvic Floor Dysfunction
  9. 1.3.3 Post-orgasmic Diseases
  10. 1.3.4 Orgasm Disorders
  11. 1.3.5 Sexual Arousal Disorders
  12. 1.3.6 Sexual Pain Disorders
  13. 1.3.7 Sexual Desire Disorders
  14. 1.3.8 Other
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Female Sexual Dysfunction Treatment Market Dynamics
  1. 2.1 Female Sexual Dysfunction Treatment Industry Trends
  2. 2.2 Female Sexual Dysfunction Treatment Industry Drivers
  3. 2.3 Female Sexual Dysfunction Treatment Industry Opportunities and Challenges
  4. 2.4 Female Sexual Dysfunction Treatment Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Female Sexual Dysfunction Treatment Market Perspective (2021-2032)
  2. 3.2 Global Female Sexual Dysfunction Treatment Growth Trends by Region
  3. 3.2.1 Global Female Sexual Dysfunction Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Female Sexual Dysfunction Treatment Market Size by Region (2021-2026)
  5. 3.2.3 Global Female Sexual Dysfunction Treatment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Female Sexual Dysfunction Treatment Revenue by Players
  2. 4.1.1 Global Female Sexual Dysfunction Treatment Revenue by Players (2021-2026)
  3. 4.1.2 Global Female Sexual Dysfunction Treatment Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Female Sexual Dysfunction Treatment Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Female Sexual Dysfunction Treatment Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Female Sexual Dysfunction Treatment Key Players Headquarters & Area Served
  7. 4.4 Global Female Sexual Dysfunction Treatment Players, Product Type & Application
  8. 4.5 Global Female Sexual Dysfunction Treatment Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Female Sexual Dysfunction Treatment Market CR5 and HHI
  11. 4.6.3 2025 Female Sexual Dysfunction Treatment Tier 1, Tier 2, and Tier 3
5 Female Sexual Dysfunction Treatment Market Size by Type
  1. 5.1 Global Female Sexual Dysfunction Treatment Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Female Sexual Dysfunction Treatment Revenue by Type (2021-2032)
  3. 5.3 Global Female Sexual Dysfunction Treatment Revenue Market Share by Type (2021-2032)
6 Female Sexual Dysfunction Treatment Market Size by Application
  1. 6.1 Global Female Sexual Dysfunction Treatment Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Female Sexual Dysfunction Treatment Revenue by Application (2021-2032)
  3. 6.3 Global Female Sexual Dysfunction Treatment Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Novo Nordisk AS
  2. 7.1.1 Novo Nordisk AS Company Information
  3. 7.1.2 Novo Nordisk AS Business Overview
  4. 7.1.3 Novo Nordisk AS Female Sexual Dysfunction Treatment Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Novo Nordisk AS Female Sexual Dysfunction Treatment Product Portfolio
  6. 7.1.5 Novo Nordisk AS Recent Developments
  7. 7.2 Sprout Pharmaceuticals Inc.
  8. 7.2.1 Sprout Pharmaceuticals Inc. Company Information
  9. 7.2.2 Sprout Pharmaceuticals Inc. Business Overview
  10. 7.2.3 Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Product Portfolio
  12. 7.2.5 Sprout Pharmaceuticals Inc. Recent Developments
  13. 7.3 Emotional Brain BV
  14. 7.3.1 Emotional Brain BV Company Information
  15. 7.3.2 Emotional Brain BV Business Overview
  16. 7.3.3 Emotional Brain BV Female Sexual Dysfunction Treatment Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Emotional Brain BV Female Sexual Dysfunction Treatment Product Portfolio
  18. 7.3.5 Emotional Brain BV Recent Developments
  19. 7.4 Duchesnay Inc.
  20. 7.4.1 Duchesnay Inc. Company Information
  21. 7.4.2 Duchesnay Inc. Business Overview
  22. 7.4.3 Duchesnay Inc. Female Sexual Dysfunction Treatment Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Duchesnay Inc. Female Sexual Dysfunction Treatment Product Portfolio
  24. 7.4.5 Duchesnay Inc. Recent Developments
  25. 7.5 AMAG Pharmaceuticals Inc.
  26. 7.5.1 AMAG Pharmaceuticals Inc. Company Information
  27. 7.5.2 AMAG Pharmaceuticals Inc. Business Overview
  28. 7.5.3 AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue and Gross Margin (2021-2026)
  29. 7.5.4 AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Product Portfolio
  30. 7.5.5 AMAG Pharmaceuticals Inc. Recent Developments
8 North America
  1. 8.1 North America Female Sexual Dysfunction Treatment Revenue (2021-2032)
  2. 8.2 North America Female Sexual Dysfunction Treatment Revenue by Type (2021-2032)
  3. 8.2.1 North America Female Sexual Dysfunction Treatment Revenue by Type (2021-2026)
  4. 8.2.2 North America Female Sexual Dysfunction Treatment Revenue by Type (2027-2032)
  5. 8.3 North America Female Sexual Dysfunction Treatment Revenue Share by Type (2021-2032)
  6. 8.4 North America Female Sexual Dysfunction Treatment Revenue by Application (2021-2032)
  7. 8.4.1 North America Female Sexual Dysfunction Treatment Revenue by Application (2021-2026)
  8. 8.4.2 North America Female Sexual Dysfunction Treatment Revenue by Application (2027-2032)
  9. 8.5 North America Female Sexual Dysfunction Treatment Revenue Share by Application (2021-2032)
  10. 8.6 North America Female Sexual Dysfunction Treatment Revenue by Country
  11. 8.6.1 North America Female Sexual Dysfunction Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Female Sexual Dysfunction Treatment Revenue by Country (2021-2026)
  13. 8.6.3 North America Female Sexual Dysfunction Treatment Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Female Sexual Dysfunction Treatment Revenue (2021-2032)
  2. 9.2 Europe Female Sexual Dysfunction Treatment Revenue by Type (2021-2032)
  3. 9.2.1 Europe Female Sexual Dysfunction Treatment Revenue by Type (2021-2026)
  4. 9.2.2 Europe Female Sexual Dysfunction Treatment Revenue by Type (2027-2032)
  5. 9.3 Europe Female Sexual Dysfunction Treatment Revenue Share by Type (2021-2032)
  6. 9.4 Europe Female Sexual Dysfunction Treatment Revenue by Application (2021-2032)
  7. 9.4.1 Europe Female Sexual Dysfunction Treatment Revenue by Application (2021-2026)
  8. 9.4.2 Europe Female Sexual Dysfunction Treatment Revenue by Application (2027-2032)
  9. 9.5 Europe Female Sexual Dysfunction Treatment Revenue Share by Application (2021-2032)
  10. 9.6 Europe Female Sexual Dysfunction Treatment Revenue by Country
  11. 9.6.1 Europe Female Sexual Dysfunction Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Female Sexual Dysfunction Treatment Revenue by Country (2021-2026)
  13. 9.6.3 Europe Female Sexual Dysfunction Treatment Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Female Sexual Dysfunction Treatment Revenue (2021-2032)
  2. 10.2 China Female Sexual Dysfunction Treatment Revenue by Type (2021-2032)
  3. 10.2.1 China Female Sexual Dysfunction Treatment Revenue by Type (2021-2026)
  4. 10.2.2 China Female Sexual Dysfunction Treatment Revenue by Type (2027-2032)
  5. 10.3 China Female Sexual Dysfunction Treatment Revenue Share by Type (2021-2032)
  6. 10.4 China Female Sexual Dysfunction Treatment Revenue by Application (2021-2032)
  7. 10.4.1 China Female Sexual Dysfunction Treatment Revenue by Application (2021-2026)
  8. 10.4.2 China Female Sexual Dysfunction Treatment Revenue by Application (2027-2032)
  9. 10.5 China Female Sexual Dysfunction Treatment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Female Sexual Dysfunction Treatment Revenue (2021-2032)
  2. 11.2 Asia Female Sexual Dysfunction Treatment Revenue by Type (2021-2032)
  3. 11.2.1 Asia Female Sexual Dysfunction Treatment Revenue by Type (2021-2026)
  4. 11.2.2 Asia Female Sexual Dysfunction Treatment Revenue by Type (2027-2032)
  5. 11.3 Asia Female Sexual Dysfunction Treatment Revenue Share by Type (2021-2032)
  6. 11.4 Asia Female Sexual Dysfunction Treatment Revenue by Application (2021-2032)
  7. 11.4.1 Asia Female Sexual Dysfunction Treatment Revenue by Application (2021-2026)
  8. 11.4.2 Asia Female Sexual Dysfunction Treatment Revenue by Application (2027-2032)
  9. 11.5 Asia Female Sexual Dysfunction Treatment Revenue Share by Application (2021-2032)
  10. 11.6 Asia Female Sexual Dysfunction Treatment Revenue by Country
  11. 11.6.1 Asia Female Sexual Dysfunction Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Female Sexual Dysfunction Treatment Revenue by Country (2021-2026)
  13. 11.6.3 Asia Female Sexual Dysfunction Treatment Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Female Sexual Dysfunction Treatment Revenue (2021-2032)
  2. 12.2 SAMEA Female Sexual Dysfunction Treatment Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Female Sexual Dysfunction Treatment Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Female Sexual Dysfunction Treatment Revenue by Type (2027-2032)
  5. 12.3 SAMEA Female Sexual Dysfunction Treatment Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Female Sexual Dysfunction Treatment Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Female Sexual Dysfunction Treatment Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Female Sexual Dysfunction Treatment Revenue by Application (2027-2032)
  9. 12.5 SAMEA Female Sexual Dysfunction Treatment Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Female Sexual Dysfunction Treatment Revenue by Country
  11. 12.6.1 SAMEA Female Sexual Dysfunction Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Female Sexual Dysfunction Treatment Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Female Sexual Dysfunction Treatment Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst